KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 130 filers reported holding KYMERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,755,070 | -39.4% | 126,264 | +0.2% | 0.00% | -100.0% |
| Q2 2023 | $2,898,027 | -89.9% | 126,056 | -87.0% | 0.00% | -83.3% |
| Q1 2023 | $28,621,615 | +15.8% | 965,967 | -2.4% | 0.01% | 0.0% |
| Q4 2022 | $24,709,551 | +10.7% | 989,966 | -3.4% | 0.01% | +20.0% |
| Q3 2022 | $22,318,000 | +10.6% | 1,025,244 | +0.1% | 0.01% | 0.0% |
| Q2 2022 | $20,175,000 | -30.5% | 1,024,662 | +49.3% | 0.01% | -16.7% |
| Q1 2022 | $29,041,000 | -13.8% | 686,194 | +29.3% | 0.01% | 0.0% |
| Q4 2021 | $33,696,000 | +14.5% | 530,718 | +6.0% | 0.01% | 0.0% |
| Q3 2021 | $29,422,000 | +784.6% | 500,880 | +630.4% | 0.01% | +500.0% |
| Q2 2021 | $3,326,000 | +123.4% | 68,580 | +78.9% | 0.00% | – |
| Q1 2021 | $1,489,000 | -40.3% | 38,336 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $2,496,000 | – | 40,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |